Mahamaya Lifesciences Confirms Corporate Governance Non-Applicability for Q2 FY27
Mahamaya Lifesciences Ltd 路 Others (Uncategorized) 路 29 Oct 2026, 10:03 pm
Mahamaya Lifesciences Confirms Corporate Governance Non-Applicability for Q2 FY27 Mahamaya Lifesciences Limited announced the non-applicability of corporate governance reporting requirements under Regulation 27(2) of SEBI LODR Regulations for the quarter ended 30th Sep'26. As an entity listed on the BSE SME platform, the company is exempt under Regulation 15(2)(b) from filing quarterly corporate governance compliance reports. Practicing Company Secretaries firm HPN & Associates issued a formal certification verifying the statutory exemption for the period.
Original exchange filing (PDF)
More announcements from Mahamaya Lifesciences Ltd
- Mahamaya Lifesciences Limited has informed the Exchange about Schedule of Meet to be held on Thursday, November 19, 2026 at 04.00 PM 路 19 Nov 2026
- Submission of Monitoring Agency Report for the half year ended September 30, 2026 路 13 Nov 2026
- Financial Results for the half year ended September 30, 2026 路 13 Nov 2026
- Outcome of Board meeting held on Today i.e. November 13, 2026 路 13 Nov 2026
- Mahamaya Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve unaudited financials .... 路 13 Nov 2026
- Publication of Executive Interview in AgroPages Magazine (2026 India Focus Issue) 路 09 Oct 2026
- Appointment of Dr. Bhagirath Choudhary as Independent Director, Re-appointment of Dr. Charudatta Digambar Mayee as Independent Director, Re-appointment of Mr. Gopal Krishna Raju as Independent .... 路 30 Sept 2026
- Mahamaya Lifesciences Limited has informed the exchange regarding the voting results and scrutinizer report of the 24th Annual General Meeting held on September 29, 2026 路 30 Sept 2026
